... Association for Molecular Pathology v.
Myriad Genetics (2013)
“Myriad’s patents would, if valid, give it the exclusive right
The Problem with Patents - Department of Plant Sciences
... • In the E8 case study, how does prior art preclude patenting?
Discuss ways research scientist could use publications as a means
to place inventions in the public domain.
• While patent law has presented opportunities to protect intellectual
property in the field of biotechnology, it has also genera ...
ethics and assignmen..
... • Inequity, poverty increase
• Thus more food and more hunger
• Green Revolution unsustainable
... flu are freely available in online public
databases. So to build a virus from
scratch, a terrorist would simply order
consecutive lengths of DNA along the
sequence and glue them together in the
correct order. This is beyond the skills
and equipment of the kitchen chemist,
but could be achieved by a ...
Transgenic crops—why gene flow matters
... related species in North America. Clearly,
there is a paucity of interdisciplinary research
on the ecological and agronomic effects of
gene flow, and increased public investment in
this type of research is sorely needed.
Gene flow from crops to wild or weedy relatives is often cited as a potential r ...
Press Release - A Thousand Invisible Cords
... “Sometimes there is a perception that curiosity about the working of seemingly trivial organisms such as
an aphid is ivory tower research of no consequence,” adds Whitham. “Yet, such research often results in
the discovery of fundamental principles. In turn, these principles result in major applica ...
Parent organism - Office of the Gene Technology Regulator
... The Act includes transitional arrangements for dealings previously approved by GMAC.
Section 190 of the Act provides for those dealings for which an advice to proceed had been
issued by GMAC prior to the commencement of the Act on 21 June 2001 to be ‘deemed’ to
be licensed for the purposes of the Ac ...
Introduction to Biotech
... • E.g. The use of living organisms or their products for
the welfare of humanity.
• E.g. The use of scientific techniques to improve or
modify plants, animals and microorganisms.
... has accelerated the pace of progress of plant breeding. Varieties developed by MAS are permitted for
use in organic farming.
We have now entered an era of climate change leading to potential adverse changes in temperature,
precipitation and sea level. We need new genes for meeting the challenges of ...
Gene drives - Wyss Institute
Supplementary Materials - Nosil Lab of Evolutionary Biology
... RI, but the genetic evidence is correlative such that another gene could be causing the association. 3: Gene known, RI only inferred.
Strong evidence is available that a gene affects a phenotypic trait under divergent selection, but effects on RI are indirectly inferred from
divergent selection. 4: ...
Technologies du Futur
... Cost. Danger of simplistic views on research. Needs some thinking
Consulted experts : P Wincker, Génoscope
Technologies du Futur - 24 Novembre 2008
... • We have now a greater critical mass of experts and
• There are many enterprises which are engaging themselves
in the process;
• The country has never supported the development of
Biotechnology as much as it is supporting nowadays(PITCE);
• For the first time the country subsidies part ...
Is gene flow from pelagic larval dispersal
... among these populations, in particular a nearly fixed difference at a malic enzymecoding locus (Me) between Massachusetts inshore and Prince Edward Island samples. The alternative alleles characteristic of these two populations were found
segregating at about equal frequencies in the offshore popula ...
C. W. Cunningham 2001
... and Swisher 1984; Olson 1985; Grosberg 1987, 1991; Stoner
1990; Willis and Oliver 1990; Jones et al. 1999; Swearer et al.
1999). In principle, these migration or dispersal patterns
could then be translated into estimates of gene flow by determining whether the movements lead to successful breeding
Non-random gene flow: an underappreciated force in evolution and
... dispersal decisions . Individuals should be more likely
to disperse if they: (i) have low local performance; or (ii)
detect the possibility of higher performance at a foreign
site. Local performance might be judged relative to some
threshold (e.g., perceived vulnerability to local predators
Non-random gene flow: an underappreciated force in
... to functional genotypes, and mostly these directly model
the evolution of the dispersal traits themselves (e.g., ).
The non-randomness of gene flow was of substantial interest during the 1960s and 1970s [42–45], then was largely
dropped and has only recently gained new attention [12–
Quarterly Report March 2009 - Office of the Gene Technology
... and considering policy principles and any relevant policy guidelines.
Once these actions are completed, the Regulator can make a decision on whether or not to grant a
licence and the conditions which are to be included in the licence if issued.
The statutory timeframes for making decisions on DIR li ...
Implications of U.S. gene patent invalidation on Australia
On 29 March 2010, the US District Court for the Southern District of New York found several of the patent claims on the BRCA1 and BRCA2 breast cancer genes held by Myriad Genetics to be invalid. The patents were initially issued on the basis that the genes were isolated and purified to a non-naturally occurring state, however the court found, amongst other things, that the purification was not markedly different from a product of nature and thus was not patentable. The ruling may have implications for holders of other gene patents and the patentability of other naturally occurring substances. It has the potential to directly affect the operation of the healthcare and medical research industries, particularly with regards to cancer treatment and prevention, and may alter the accessibility of such therapies to patients.Myriad Genetics' patents for the testing of the breast cancer genes are currently licensed for use in Australia to Genetic Technologies Limited. Genetic Technologies attempted to enforce its rights and stop other laboratories from performing the tests as recently as 2008, but was forced to back down following public protest. The US court decision has prompted further debate about the legitimacy of gene patents in Australia. A Federal Government inquiry into the issue is currently underway and is expected to report in September 2013.